Albitride Tablet

Adult dose

Typically taken orally 1 tablet twice daily, regardless of meal timing, in the morning and before bedtime. 1) Gastric and duodenal ulcers: Administer 1 tablet twice daily or 2 tablets once daily before bedtime. Particularly for patients with duodenal ulcers, administering 2 tablets twice daily in the morning and at bedtime can achieve a higher treatment rate. 2) Gastroesophageal reflux disease: Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily before bedtime.

This medication should not be used in patients undergoing dialysis or those with kidney function problems. In addition, it should not be administered to individuals who have had allergic reactions to this medication or its components, patients with a history of acute porphyria, those who have undergone upper gastrointestinal tract surgery, pregnant women, women who may become pregnant, premature infants, and newborns on potassium-restricted diets. Patients with liver function impairment or a history of drug allergies, the elderly, and those with a past history of kidney impairment should use this medication with caution. Patients taking non-steroidal anti-inflammatory drugs, especially the elderly or those with a history of peptic ulcers, should be regularly monitored. This medication may mask symptoms of gastric cancer; therefore, patients with gastric ulcers or those who develop new or altered digestive symptoms over middle age should undergo procedures to rule out malignant conditions before administration. Patients with Helicobacter pylori gastric or duodenal ulcers should undergo bacterial eradication therapy. Special attention is required for severely ill patients in the intensive care unit, those with hypophosphatemia, or those with swallowing difficulties. Rarely, during the use of this medication, severe allergic reactions, blood-related abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neuropsychiatric symptoms may occur, so any unusual symptoms should be reported to medical personnel immediately. In particular, if dizziness or drowsiness occurs, it is advisable to avoid driving or operating hazardous machinery. It is recommended not to use this medication for extended periods, and if there is no therapeutic effect, it should be switched to another medication. Moreover, this medication may interact with other drugs, so it is essential to inform medical personnel of any other medications being taken. It is safest for pregnant or potentially pregnant women, as well as nursing mothers, to avoid using this medication. Children should not be given this medication as its safety and efficacy have not been adequately established in this population. In cases of overdose, emergency measures such as vomiting or gastric lavage may be needed, and blood dialysis may be used to remove the drug if necessary. Finally, this medication reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract, and prolonged use may affect eye health, necessitating an ophthalmological examination.

Serious side effects

• Anaphylactic shock
• urticaria
• angioedema
• chest pain
• bronchospasm
• hypotension
• tachycardia
• bradycardia
• heart block
• premature ventricular contractions

Mild side effects

• Skin rash
• urticaria
• angioedema
• fever
• bronchospasm
• hypotension
• chest pain
• nausea
• vomiting
• constipation

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius. This helps to prolong the drug's efficacy.

Appearance

Green oblong film-coated triple tablet

Package unit

30 tablets/bottle, 300 tablets/bottle